CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 44 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,855,274 | -31.0% | 2,132,744 | -11.1% | 0.03% | -26.1% |
| Q2 2023 | $2,688,385 | +7.7% | 2,400,344 | 0.0% | 0.05% | +9.5% |
| Q1 2023 | $2,496,358 | -7.1% | 2,400,344 | 0.0% | 0.04% | -14.3% |
| Q4 2022 | $2,688,385 | -0.9% | 2,400,344 | 0.0% | 0.05% | -15.5% |
| Q3 2022 | $2,712,000 | -22.8% | 2,400,344 | +0.4% | 0.06% | -21.6% |
| Q2 2022 | $3,514,000 | -38.3% | 2,390,344 | -3.8% | 0.07% | -19.6% |
| Q1 2022 | $5,692,000 | -33.5% | 2,485,652 | -20.2% | 0.09% | -23.3% |
| Q4 2021 | $8,565,000 | -43.5% | 3,114,252 | +23.3% | 0.12% | -36.5% |
| Q3 2021 | $15,156,000 | -9.0% | 2,525,952 | -26.1% | 0.19% | -2.1% |
| Q2 2021 | $16,655,000 | +90.4% | 3,419,877 | -3.4% | 0.19% | +93.0% |
| Q1 2021 | $8,746,000 | -9.9% | 3,540,961 | 0.0% | 0.10% | -1.0% |
| Q4 2020 | $9,702,000 | +158.1% | 3,540,961 | +45.1% | 0.10% | +129.5% |
| Q3 2020 | $3,759,000 | +3.2% | 2,440,961 | +26.0% | 0.04% | -12.0% |
| Q2 2020 | $3,643,000 | +8.2% | 1,937,608 | -2.2% | 0.05% | -12.3% |
| Q1 2020 | $3,367,000 | – | 1,980,508 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 169,629 | $147,560 | 0.05% |
| BROWN WEALTH MANAGEMENT, LLC | 110,000 | $95,689 | 0.05% |
| Carmignac Gestion | 2,132,744 | $1,855,274 | 0.03% |
| WATER ISLAND CAPITAL LLC | 82,500 | $72 | 0.01% |
| Northeast Financial Consultants Inc | 83,000 | $72,202 | 0.01% |
| XTX Topco Ltd | 27,545 | $23,961 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,600 | $152,754 | 0.00% |
| Curi Wealth Management, LLC | 25,000 | $21,748 | 0.00% |
| Banque Cantonale Vaudoise | 40,000 | $35 | 0.00% |
| SYNOVUS FINANCIAL CORP | 58,071 | $50,516 | 0.00% |